InKaryo Overview
- Founded
- 2013
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
InKaryo General Information
Description
Provider of cytogenetic analysis services. The company's experimental protocol and proprietary bioinformatics analysis cover the full genome evenly with specific and accurate digital sequence output thus providing next generation sequencing platforms, sequencing reagents, sequencing applications, genomic diagnostics, and bioinformatics.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Outcome Management (Healthcare)
Other Industries
Other Healthcare
Other Healthcare Technology Systems
Parent Company
Primary Office
- NASA Research Park
- MS 239-24, Building 239 Rm 175
- Mountain View, CA 94035
- United States
+1 (650) 000-0000
InKaryo Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore InKaryo‘s full profile, request access.
Request a free trialInKaryo Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Xitong Li | Co-Founder and President | ||
| Zhenbin Fan | Co-Founder |